Cytalux (pafolacianince), a drug that binds to ovarian cancer tissue and glows when exposed to fluorescent light, has been approved by the U.S. Food and Drug Administration (FDA) to help surgeons detect ovarian tumors during surgical procedures in patients.
Government health advisers on Tuesday weighed the benefits and risks of a closely watched drug from Merck that could soon become the first U.S.-authorized pill for patients to take at home to treat COVID-19.
The University of Oxford said Tuesday there was no evidence that current COVID-19 vaccines would not continue to protect against severe disease from the omicron variant.
The Centers for Disease Control and Prevention (CDC) on Monday updated agency guidance to advise that anyone over age 18 should receive a COVID-19 booster shot.
With New York City health officials anticipating the omicron variant to arrive in the coming days, the city’s top doctor on Monday recommended that New Yorkers wear COVID-19 masks "at all times" indoors and in public settings regardless of their vaccination status.
The World Health Organization says it could still take some time to get a full picture of the threat posed by omicron, a new variant of the coronavirus as scientists worldwide scramble to assess its multiple mutations.
The COVID-19 omicron variant has an “unprecedented number of spike mutations” and poses a “very high” global risk, the World Health Organization said Monday.
A married couple who tested positive for COVID-19 left their hotel quarantine and were arrested in an “airplane that was about to” leave the country, Dutch military police said, according to a report.
Children face a deluge of electronic information from traditional television and computers to tablets, smartphones and video games, but prior studies examining the impact of electronic media on children and adults have yield mixed results.
A new study published in Medicine & Science in Sports & Exercise addressed the age-old question: does exercise make us eat more afterwards or decrease our appetite for the next meal?
South Africa's Dr. Angelique Coetzee who first alerted authorities to the presence of the COVID-19 omicron variant reported that it presents "unusual but mild" symptoms.
The U.S. Centers for Disease Control and Prevention (CDC) said Friday night that no cases of the omicron COVID-19 variant have been identified in the U.S. to date.
Scientists are working to determine the potential risks associated with the new COVID-19 variant called B.1.1.529, which has already prompted an emergency meeting on Friday by the World Health Organization.
The World Health Organization (WHO) announced that it would classify the new B.1.1.529 COVID-19 strain as a "variant of concern," and labeled it with the Greek alphabet letter “omicron.”
U.S. scientists will talk with South African scientists on Friday about the threat of the new B.1.1.529 COVID-19 variant, including whether or not it can evade antibodies.
The World Health Organization is holding a meeting Friday to discuss the dramatic rise in COVID-19 cases in South Africa that has been blamed on a new variant of the virus.
